Charlotte Zajc
Dr. Charlotte Zajc
Institut Institute of Biochemistry (DCH/BC)
Location Gregor-Mendel-Straße 33, 1180 Wien
Email charlotte.zajc@boku.ac.at
Tel: +43 1 47654-77279
Research Focus
Cellular cancer immunotherapies, CAR T cells, Protein Engineering, signal transduction in CAR T cells
Career
- 2024 Senor Postdoc
- 2022 - 2023 Maternity leave
- 2020 - 2024 Postdoc (Department of Chemistry, BOKU, CD Lab for next generation CAR T cells)
- 2018 - 2019 Research stay at Stanford School of Medicine
- 2016 - 2020 PhD student at the St.Anna Children´s Cancer Research Institute
- 2015 - 2016 Master thesis at the St. Anna Children´s Cancer Research Institute
- 2013 - 2015 Master studies „Biotechnology“ (University of Natural Resources and Life Sciences)
- 2008 - 2013 Bachelorstudies "Food- and Biotechnology" (University of Natural Resources and Life Sciences)
Awards
- 2023 For Women in Science Fellowship L´Oreal & UNESCO Austria
- 2021 Life Science Research Award, ÖGMBT
- 2020 BOKU Best Paper Award
- 2020 BOKU Erfindung des Jahres 2020
- 2020 BOKU Talent Award
Projects
0 Projects found.
Publications
Knowledge Transfer to Society
Media
Lectures
(2024) Engineering of molecular ON- and OFF-switches for controlling CAR T cells
Autoren: Charlotte U. Zajc, Delia Sumesgutner, Julia Mayer, Elise Sylvander, Magdalena Teufl, Manfred Lehner, Michael W. Traxlmayr
EBMT-EHA 6th European CAR T-cell Meeting
(2023) Unraveling the FMC63-CD19 affinity
Autoren: Seigner, J; Zajc, CU; Dötsch, S; Eigner, C; Laurent, E; Busch, DH; Lehner, M; Traxlmayr, MW
Keystone meeting on Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
(2023) Engineering molecular switches for functional control of CAR T cells with an orally available small molecule drug.
Autoren: Zajc, CU; Dobersberger, M; Schaffner, I; Mlynek, G; Pühringer, D; Salzer, B; Djinović-Carugo, K; Obinger, C; Lehner, M; Traxlmayr, MW
EHA-EBMT 5th European CAR T-cell Meeting
(2023) Taking control of CAR T cells- Engineering of molecular ON-switches for cellular therapies
Autoren: Charlotte U. Zajc, Markus Dobersberger, Manfred Lehner and Michael W. Traxlmayr
ÖGMBT Annual Meeting
(2020) A conformation-specific ON-switch for controlling CAR T cells with an orally available drug
Autoren: Brey, C.U.; Dobersberger, M.; Schaffner, I.; Salzer, B.; Obinger, C.; Holter, W.; Traxlmayr, M.W.; Lehner, M.
Keystone-Emerging cellular therapies